Summary
Updated Aug 30, 2026
Jacqualyn A. Fouse is Director of AGIOS PHARMACEUTICALS, INC. (AGIO). 4 SEC Form 4 filings on record going back to 2025, most recently on 23 June 2026.
Recent Transactions
4Every recent SEC Form 4 transaction Jacqualyn A. Fouse has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jacqualyn A. Fouse files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Herve Hoppenot - $19.77M of INCY open-market activity in the last 12 months
- Pablo J. Cagnoni - $11.30M of INCY open-market activity in the last 12 months
- Kenneth Bate - $8.03M of MDGL open-market activity in the last 12 months
- William John Sibold - $7.49M of MDGL open-market activity in the last 12 months
- Richard S. Levy - $7.36M of MDGL open-market activity in the last 12 months
- Steven H. Stein - $6.27M of INCY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jacqualyn A. Fouse?
Jacqualyn A. Fouse is a corporate insider, tracked as Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jacqualyn A. Fouse submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Where can I see all of Jacqualyn A. Fouse's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jacqualyn A. Fouse and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
